Found: 2
Select item for more details and to access through your institution.
Redirected cellular cytotoxicity by infection of effector cells with a recombinant vaccinia virus encoding a tumor-specific monoclonal antibody.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 4, p. 615, doi. 10.1038/sj.cgt.7700161
- By:
- Publication type:
- Article
Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUC1-positive advanced cancer.
- Published in:
- Journal of Gene Medicine, 2003, v. 5, n. 8, p. 690, doi. 10.1002/jgm.397
- By:
- Publication type:
- Article